FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy Read more
Aerpio Announces Completion of Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathy Read more
Zymeworks Reports Second Investigational New Drug (IND)-Submission Milestone Achieved in Lilly Collaboration Read more
Lipocine’s NASH Therapy Candidate Achieves Meaningful Liver Fat Reduction Based on Interim Results Read more
Ablexis Announces Expansion of Non-Exclusive Perpetual License Agreement with Eli Lilly and Company Read more
Invitation from Roderick E. Hubbard at Vernalis Research chairing SMi’s Drug Discovery Conference Read more
Human Factor Considerations in Pre-Filled Syringes Development – Focus of SMi’s Pre-Filled Syringes East Coast USA Annual Conference Read more